Inspire Medical Systems, Inc. to Present at the 2019 RBC Capital Markets Global Healthcare Conference

Download as PDF

MINNEAPOLIS, MN – May 8, 2019 – Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire),
a medical technology company focused on the development and commercialization of innovative
and minimally invasive solutions for patients with obstructive sleep apnea, announced today that
its management team will be presenting at the 2019 RBC Capital Markets Global Healthcare
Conference on May 22, 2019 at the InterContinental New York Barclay in New York City.
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible
via a live webcast at: www.veracast.com/webcasts/rbc/healthcare2019/87314450599.cfm.
A webcast replay of the presentation will be available for two weeks following the presentation
in the Event Archive section of Inspire’s Investor website at www.investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of
innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s
proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that
provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989